Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere are three places to inject Mounjaro: the abdomen, the front of the thigh, and the outer upper arm. Each site is licensed for use in the Mounjaro SmPC, and rotating between them each week helps the skin stay healthy and the medicine absorb consistently. Mounjaro (tirzepatide) is a prescription-only medicine, so before your first injection your prescriber will confirm the technique and injection sites that suit you. The NHS patient guide on tirzepatide and the Patient Information Leaflet supplied with your pen are the two best references to keep to hand.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The abdomen is the site most people start with. Use the fatty area around the belly button, staying at least 5 cm away from it, and avoiding the navel itself. There is usually more subcutaneous tissue here than at other sites, which makes inserting the needle straightforward. If the abdomen is uncomfortable (perhaps after surgery or during pregnancy) the front of the thigh is an equally valid option. Aim for the outer, middle portion of the thigh: not the inner thigh, and not the knee or groin area. The outer upper arm (the fatty tissue at the back-outside of the arm) is the third choice; it is slightly harder to self-inject here, so it is more commonly used when someone else administers the dose.
A question our prescribers hear regularly is whether one site works better than the others, and our guide covering where is the best place to inject Mounjaro looks at this in detail. The clinical evidence does not firmly rank them for weight-loss effect, so personal comfort and consistency tend to be the deciding factors. The Mounjaro SmPC on the electronic Medicines Compendium (eMC) lists all three sites as appropriate; the specific wording in your own Patient Information Leaflet is always the definitive reference.
One thing worth setting straight: some people assume the stomach site is only for people with a lot of abdominal fat. That is not accurate. If you are still deciding, our page on the best place to inject Mounjaro walks through the practical differences between sites for different body types. The abdomen is a viable site for most adults regardless of build, because Mounjaro is injected subcutaneously (into the layer of fat just beneath the skin) and pinching the skin before inserting the needle helps regardless of body size.
Clean the skin with an alcohol swab and let it dry fully before injecting) damp skin can cause a slight stinging sensation. Wipe once and wait a few seconds. Avoid injecting into skin that is bruised, scarred, irritated or has stretch marks, and do not inject through clothing. Take the Mounjaro KwikPen from the fridge and let it reach room temperature for a few minutes: a cold pen can feel more uncomfortable going in.
Change the needle with each injection. Reusing needles makes them blunter, which increases discomfort and the chance of skin reactions. If you are running low on needles, compatible replacement needles are available separately. After injecting, dispose of used needles immediately in a puncture-resistant sharps container, never in household waste or recycling.
Storage matters here too. Mounjaro should be kept refrigerated at 2–8°C; there is a limited window during which it may be kept at room temperature, but the exact duration is specific to the product and printed in the Patient Information Leaflet. When in doubt, back in the fridge.
Rotation is not optional. Injecting repeatedly into the same small patch of skin causes lipohypertrophy, a hardening and thickening of the fatty tissue that slows absorption and can make the medicine less predictable. The fix is straightforward: move the injection spot at least 1–2 cm from last week's location, cycling around the site before moving to a different one.
A simple system many people use: three sites in rotation week by week (abdomen week 1, thigh week 2, upper arm week 3, abdomen again), and within each site they work their way around a rough clock face. Written records or a phone note take three seconds and remove all guesswork. Detailed guidance on how to approach your Mounjaro injection points goes deeper into rotation patterns if you want a more structured plan.
People using Mounjaro alongside insulin for type 2 diabetes should be careful not to use the same site at the same injection time, the two medicines interact with each other if injected in the same area on the same day. That is a conversation for your prescriber, and our resource on where's best place to inject Mounjaro also touches on considerations for people managing more than one injectable medicine.
Mild redness, a small bruise or slight itching at the injection site are common and usually resolve within a day or two. You can read more about what to expect in our guide to the Mounjaro injection process, which covers technique alongside side-effect management. Signs that need prompt attention include swelling that spreads beyond the immediate area, persistent hard lumps that do not soften over several weeks, or skin changes (discolouration, pitting). Tell your prescriber at your next review, or contact us sooner through our 7-day aftercare team if you are uncertain.
Systemic side effects (nausea, indigestion, fatigue) are separate from injection-site reactions and are related to the medicine itself rather than where it was given. If any symptoms concern you, reporting them via the MHRA Yellow Card scheme helps build the ongoing safety picture for Mounjaro in the UK.
Understanding how treatment is costed is also useful groundwork, if you are still weighing up your options, our Mounjaro cost page sets out the full picture honestly. When you are ready to discuss whether Mounjaro is right for you, start your free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.